Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
IMPAX Laboratories, Inc.
IMPAX Sued Based on ANDA for Generic Doryx®
January 17th, 2009
IMPAX Laboratories, Inc. announced that Warner Chilcott Laboratories Ireland Limited, Warner Chilcott Company, Inc., Warner Chilcott (US) LLC, and Mayne Pharma International PTY. LTD have filed suit for patent infringement in the United States District Court for the District of New Jersey based on the Company’s submission of Abbreviated New Drug Application (“ANDA”) for doxycycline hyclate delayed-release tablets (75 and 100 mg), generic of Doryx®, to the Food and Drug Administration. In connection with this ANDA, IMPAX provided notice that its submission includes a Paragraph IV certification stating the Company believes its product does not infringe U.S. Patent No. 6,958,161, or the...
Source: Law & Health Weekly (2009-01-17)
|
